Hermetica Superfood Encyclopedia
The Short Answer
Thalassiosira pseudonana synthesizes L-ascorbic acid (Vitamin C) as a component of its intracellular soluble cofactor pool, where it functions as a primary antioxidant and enzymatic redox cofactor, broadly analogous to ascorbic acid from any source in its capacity to donate electrons and regenerate oxidized biomolecules. However, species-specific Vitamin C concentrations in T. pseudonana remain unquantified in peer-reviewed literature, with broader microalgal Vitamin C content ranging from 0.06 to 18.79 mg/g dry weight, and no human clinical trials have validated this particular source for nutritional efficacy or superior bioavailability over conventional ascorbic acid.
CategoryVitamin
GroupMarine-Derived
Evidence LevelPreliminary
Primary KeywordThalassiosira pseudonana vitamin C
Microalgal Vitamin C — botanical close-up
Health Benefits
**Antioxidant Defense**
L-ascorbic acid from microalgal sources donates electrons to neutralize reactive oxygen species (ROS), regenerating oxidized glutathione and vitamin E and protecting cellular lipids, proteins, and DNA from oxidative damage characteristic of marine-derived ascorbate.
**Immune System Modulation**
Ascorbic acid stimulates proliferation and function of lymphocytes and phagocytes, enhances neutrophil chemotaxis, and supports cytokine production; these mechanisms are attributed to the ascorbic acid molecule itself regardless of source.
**Collagen Biosynthesis Support**
Vitamin C serves as a required cofactor for prolyl and lysyl hydroxylase enzymes that stabilize the triple-helix structure of collagen, underpinning skin integrity, wound healing, and connective tissue maintenance.
**Neuromodulatory and Cofactor Roles**
Ascorbic acid supports dopamine beta-hydroxylase activity in catecholamine synthesis and acts as a cofactor in carnitine biosynthesis, with microalgal co-production of other B-vitamins potentially offering a complementary nutritional matrix.
**Iron Absorption Enhancement**
Vitamin C reduces ferric iron (Fe³⁺) to the more bioavailable ferrous form (Fe²⁺) in the gastrointestinal tract, improving non-heme iron uptake; this function is intrinsic to ascorbic acid chemistry and would apply to any food-matrix source including microalgae.
**Potential Synergistic Phytonutrient Context**: T
pseudonana biomass contains co-occurring pigments (fucoxanthin precursors), omega-3 fatty acids, and polysaccharides such as chrysolaminarin that may theoretically modulate the bioavailability or antioxidant context of its Vitamin C content, though this has not been empirically tested.
**Cardiovascular Antioxidant Support**
Ascorbic acid inhibits LDL oxidation and supports endothelial nitric oxide synthase (eNOS) function by maintaining tetrahydrobiopterin (BH4) availability; extrapolation of these well-established ascorbate mechanisms to T. pseudonana-derived Vitamin C is mechanistically plausible but clinically unverified.
Origin & History
Natural habitat
Thalassiosira pseudonana is a unicellular marine diatom microalga found in coastal and open ocean waters worldwide, particularly in temperate and polar seas where it thrives in nutrient-rich, cold-to-moderate temperature conditions. It is cultivated in controlled photobioreactor or open-tank aquaculture systems under specific light, salinity, and nutrient regimes for research and biotechnological purposes, achieving optimal growth at densities around 10^4 cells/mL. Unlike terrestrial botanical sources, T. pseudonana produces Vitamin C (L-ascorbic acid) as part of its intracellular soluble vitamin pool, synthesized endogenously as a redox cofactor supporting metabolic and antioxidant functions within its silica-encased frustule biomass.
“Thalassiosira pseudonana has no documented history of traditional human medicinal or dietary use in any culture; it was first formally described and named as a scientific specimen in the 20th century and has been studied almost exclusively in the context of marine ecology, oceanography, and biotechnology. Indigenous coastal communities have historically consumed various macroalgae and some microalgae-rich preparations, but T. pseudonana specifically—being a microscopic, single-celled planktonic diatom—would not have been identifiable or intentionally harvested as a discrete ingredient in any pre-modern tradition. Its prominence in science arises from its status as the first marine eukaryotic microalga to have its complete genome sequenced (published in Nature in 2004), making it a model organism for diatom biology, lipid metabolism, and silicon cycling rather than a medicinal plant with cultural heritage. Preparation methods in all recorded literature are strictly laboratory procedures including photobioreactor cultivation, cell density monitoring by hemocytometer, and fluorescent staining protocols such as PDMPO for silica deposition studies, none of which constitute traditional ethnomedicinal preparation.”Traditional Medicine
Scientific Research
The scientific evidence base for Vitamin C specifically derived from Thalassiosira pseudonana as a human nutritional ingredient is effectively absent; no peer-reviewed clinical trials, pharmacokinetic studies, or controlled human intervention studies have been published investigating this source. Broader microalgal Vitamin C research is limited and largely confined to in vitro antioxidant capacity assays and compositional analyses, with one survey of commercial microalgae reporting Vitamin C content of 490.4–711.8 mg/kg dry weight across mixed species but without species-level resolution for T. pseudonana. The mechanistic and clinical evidence for L-ascorbic acid itself—derived from extensive trials across synthetic and food-matrix sources—is robust and well-established, but this evidence cannot be directly transferred to validate T. pseudonana as a clinically superior, equivalent, or even quantifiably significant Vitamin C source without source-specific bioavailability and compositional data. Published research on T. pseudonana primarily addresses its genome-scale metabolic modeling, ecological co-culture dynamics, silica frustule biology, and lipid/pigment profiles rather than human nutritional or medicinal applications, representing a fundamental gap in translational evidence.
Preparation & Dosage
Traditional preparation
**Whole Biomass Powder (Theoretical)**
79 mg/g DW based on microalgal range data, but no standardized extract or dose has been established
T. pseudonana is not currently commercialized as a Vitamin C supplement; if biomass powder were prepared, Vitamin C content would be estimated at 0.06–18..
**Aqueous Extract (Research Context Only)**
Laboratory cultivation involves growing T. pseudonana in f/2 or artificial seawater media under controlled photoperiod; no human-grade aqueous extract preparation or standardization protocol exists.
**Reference Ascorbic Acid Dose (Class-Level Guidance)**
75–90 mg/day for adults, with therapeutic doses of 200–1000 mg/day used in clinical research, but these are not validated for T
The Recommended Dietary Allowance (RDA) for Vitamin C is . pseudonana-sourced ascorbate.
**Tolerable Upper Intake Level**
2000 mg/day in adults, above which osmotic diarrhea and gastrointestinal distress are reported; this limit would apply by chemical class but has not been tested for this source
The established UL for Vitamin C from any source is .
**Timing and Administration Notes**
Ascorbic acid from food matrices is generally best absorbed in divided doses with meals; whether T. pseudonana biomass matrix alters absorption kinetics is entirely unknown.
Nutritional Profile
T. pseudonana biomass encompasses a complex matrix of macronutrients and micronutrients: proteins account for approximately 20–35% of dry weight (species-variable), lipids for 5–20% DW including eicosapentaenoic acid (EPA, 20:5n-3) as a notable omega-3 fatty acid, and carbohydrates including the storage polysaccharide chrysolaminarin and structural chitin from the frustule girdle bands. Micronutrients include a soluble vitamin pool confirmed to contain Vitamin C, B-vitamins (including B12 precursors reported in related diatoms), and cofactors, though species-specific quantification for each vitamin is absent from peer-reviewed literature; broader microalgal Vitamin C ranges from 0.06 to 18.79 mg/g DW suggest potentially significant but highly variable content. Pigments including fucoxanthin (a carotenoid with documented antioxidant and anti-inflammatory activity in related diatoms) and chlorophyll a contribute to the phytochemical profile, and the silica frustule—comprising amorphous SiO₂—represents a significant ash fraction that is biologically inert but distinguishes diatom biomass from conventional botanical sources. Bioavailability of Vitamin C from T. pseudonana biomass is entirely uncharacterized; the silica frustule matrix may theoretically influence cell wall disruption and intracellular nutrient release during digestion, a factor not yet investigated.
How It Works
Mechanism of Action
L-ascorbic acid (Vitamin C), as present in T. pseudonana's intracellular soluble pool, exerts its antioxidant effects primarily through sequential one-electron oxidation steps, converting to ascorbyl radical and then dehydroascorbic acid (DHA) while quenching superoxide, hydroxyl radicals, and singlet oxygen; ascorbyl radical is sufficiently stable to limit propagation of oxidative chain reactions. As an enzyme cofactor, ascorbate supplies reducing equivalents to dioxygenase enzymes including prolyl-4-hydroxylase (EC 1.14.11.2) and lysyl hydroxylase (EC 1.14.11.4) critical for collagen maturation, as well as peptidylglycine alpha-amidating monooxygenase (PAM) involved in neuropeptide synthesis, mechanisms rooted in the ascorbate molecule and not specific to its microalgal origin. Intracellularly, ascorbate is concentrated via sodium-dependent vitamin C transporters (SVCT1 and SVCT2) and participates in the glutathione-ascorbate antioxidant cycle, where monodehydroascorbate reductase and dehydroascorbate reductase enzymes regenerate reduced ascorbate at the expense of NADPH and glutathione. No molecular-level data specific to T. pseudonana-derived ascorbate—including potential matrix effects from co-occurring diatom biomolecules such as chrysolaminarin, silica frustule components, or eicosapentaenoic acid (EPA)—have been characterized in human biological systems.
Clinical Evidence
No clinical trials have been conducted specifically evaluating Vitamin C from Thalassiosira pseudonana in human subjects, and therefore no outcome data, effect sizes, or confidence intervals can be reported for this particular source. The clinical evidence for L-ascorbic acid as a molecule—drawn from hundreds of randomized controlled trials across synthetic ascorbic acid, acerola, rosehip, and other food sources—demonstrates well-characterized benefits in immune function, collagen synthesis, and antioxidant status, but these findings cannot be attributed to T. pseudonana without source-specific trials. Extrapolation is further limited because the Vitamin C concentration in T. pseudonana biomass has not been precisely quantified, meaning the effective dose delivered per gram of biomass remains unknown, making dose-response relationships impossible to establish. Until controlled bioavailability studies, compositional standardization, and at minimum Phase I human safety trials are conducted with T. pseudonana-derived Vitamin C, clinical confidence in this ingredient specifically remains at the lowest evidence tier.
Safety & Interactions
No human safety data, adverse event reports, toxicology studies, or pharmacovigilance records exist for Thalassiosira pseudonana biomass or its derived Vitamin C as a consumed nutritional ingredient, representing a critical and complete evidence gap that precludes any safety assurance specific to this source. By chemical class, L-ascorbic acid at doses below 2000 mg/day is well-tolerated in most adults, with gastrointestinal effects (nausea, diarrhea, osmotic cramping) being dose-limiting at high intakes, and rare risks of oxalate nephrolithiasis in predisposed individuals at sustained high doses; these class-level risks would theoretically apply but cannot be confirmed for this matrix. Drug interactions known for ascorbic acid include potential interference with anticoagulant monitoring (high-dose ascorbate may falsely lower INR readings), reduced efficacy of certain chemotherapeutic agents at pharmacological doses, and enhanced iron absorption that may be hazardous in hemochromatosis; none of these interactions have been studied in the context of T. pseudonana-derived ascorbate. Pregnancy and lactation safety is unestablished for this specific source; T. pseudonana biomass consumption during pregnancy or breastfeeding cannot be recommended given the complete absence of toxicological data, and use as a Vitamin C supplement in these populations should rely on established, characterized sources.
Synergy Stack
Hermetica Formulation Heuristic
Featured in
Meru
Marine collagen with hyaluronic acid for skin, hair & joints.
Shop Now →
Also Known As
Thalassiosira pseudonanamarine diatom vitamin Cdiatom microalgae ascorbic acidT. pseudonana ascorbate
Frequently Asked Questions
How much Vitamin C does Thalassiosira pseudonana contain?
The precise Vitamin C concentration in Thalassiosira pseudonana has not been quantified in peer-reviewed scientific literature. Based on surveys of microalgae broadly, Vitamin C content across species ranges from 0.06 to 18.79 mg per gram of dry weight, and commercial microalgal products have been measured at approximately 0.49–0.71 mg/g dry weight, but T. pseudonana specifically lacks a validated compositional figure for ascorbic acid.
Is Thalassiosira pseudonana used as a Vitamin C supplement in humans?
No, Thalassiosira pseudonana is not currently commercialized or approved as a Vitamin C supplement for human use. It is studied almost entirely in marine ecology, biotechnology, and genome-scale metabolic modeling contexts, and no regulatory body has evaluated it as a nutritional ingredient; its Vitamin C content is an incidental finding of compositional analysis rather than the basis of any consumer product.
Are there any clinical trials on Vitamin C from microalgae like T. pseudonana?
No clinical trials have been conducted specifically on Vitamin C derived from Thalassiosira pseudonana, and the broader body of microalgal Vitamin C clinical research is essentially absent from the peer-reviewed literature. Extensive clinical evidence exists for ascorbic acid as a molecule from synthetic and botanical sources, but these findings cannot be directly applied to T. pseudonana without source-specific bioavailability and safety studies.
What makes diatom-derived Vitamin C different from regular ascorbic acid?
Chemically, L-ascorbic acid is identical regardless of biological source, meaning its core antioxidant and cofactor mechanisms are the same whether derived from T. pseudonana, citrus fruit, or synthetic production. The potential distinction lies in the delivery matrix: diatom biomass co-contains EPA omega-3 fatty acids, fucoxanthin-related pigments, chrysolaminarin polysaccharides, and silica frustule structures that could theoretically influence absorption kinetics or provide complementary bioactivities, but no studies have demonstrated matrix-specific bioavailability differences for T. pseudonana ascorbate.
Is it safe to consume Thalassiosira pseudonana biomass for its Vitamin C content?
The safety of consuming T. pseudonana biomass as a Vitamin C source has not been evaluated in human toxicology or clinical studies, and no regulatory Generally Recognized As Safe (GRAS) status or Novel Food authorization exists for this species as a human dietary ingredient. While ascorbic acid itself is safe at doses below 2000 mg/day by established class-level evidence, the whole biomass matrix—including its silica frustule, potential marine contaminants from cultivation media, and uncharacterized minor metabolites—requires independent safety assessment before human supplementation can be responsibly recommended.
How does Vitamin C from Thalassiosira pseudonana support immune function compared to synthetic ascorbic acid?
Vitamin C from T. pseudonana stimulates the proliferation and function of lymphocytes and phagocytes, key immune cells that fight infections and remove pathogens. While both forms provide ascorbic acid's immune benefits, the diatom-derived source may offer additional bioactive compounds from the microalgae matrix that enhance overall immune modulation. Research on marine-derived ascorbate suggests these sources may provide synergistic nutritional advantages beyond isolated vitamin C.
Can Thalassiosira pseudonana-derived Vitamin C help protect against oxidative stress and cellular damage?
Yes—Vitamin C from T. pseudonana functions as a potent antioxidant by donating electrons to neutralize reactive oxygen species (ROS) that damage cells. This process regenerates other critical antioxidants like reduced glutathione and vitamin E while protecting cellular lipids, proteins, and DNA from oxidative damage. The microalgal source delivers this protection through a form of ascorbic acid naturally synthesized in marine environments.
What environmental or sustainability advantages does Thalassiosira pseudonana Vitamin C offer compared to land-based sources?
T. pseudonana is a diatom that grows in marine or freshwater cultivation systems, requiring minimal land use and fewer agricultural inputs compared to plant-based Vitamin C sources like rose hips or kakadu plums. Microalgae-based production can operate year-round in controlled bioreactors with lower water footprint and carbon emissions than conventional farming. This makes diatom-derived Vitamin C an environmentally efficient alternative for supplement manufacturers seeking sustainable ingredient sourcing.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w vitamin-c-from-thalassiosira-pseudonana-thalassiosira-pseudonana curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
